CARGO Therapeutics Inc
NASDAQ:CRGX
Intrinsic Value
The intrinsic value of one CRGX stock under the Base Case scenario is 7.98 USD. Compared to the current market price of 4.06 USD, CARGO Therapeutics Inc is Undervalued by 49%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
CARGO Therapeutics Inc
Fundamental Analysis

Revenue & Expenses Breakdown
CARGO Therapeutics Inc
Balance Sheet Decomposition
CARGO Therapeutics Inc
Current Assets | 345m |
Cash & Short-Term Investments | 339.7m |
Receivables | 2m |
Other Current Assets | 3.3m |
Non-Current Assets | 69m |
Long-Term Investments | 28.4m |
PP&E | 34.8m |
Other Non-Current Assets | 5.9m |
Free Cash Flow Analysis
CARGO Therapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
CARGO Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-187.4m
USD
|
Operating Income
|
-187.4m
USD
|
Other Expenses
|
19.9m
USD
|
Net Income
|
-167.5m
USD
|
CRGX Profitability Score
Profitability Due Diligence
CARGO Therapeutics Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
Score
CARGO Therapeutics Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
CRGX Solvency Score
Solvency Due Diligence
CARGO Therapeutics Inc's solvency score is 80/100. The higher the solvency score, the more solvent the company is.
Score
CARGO Therapeutics Inc's solvency score is 80/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CRGX Price Targets Summary
CARGO Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for CRGX is 10.89 USD with a low forecast of 3.74 USD and a high forecast of 29.4 USD.
Dividends
Current shareholder yield for CRGX is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one CRGX stock under the Base Case scenario is 7.98 USD.
Compared to the current market price of 4.06 USD, CARGO Therapeutics Inc is Undervalued by 49%.